MRG-binding protein contributes to colorectal cancer development

Cancer Science

Volumn 102, Issue 8, 2011, Pages 1486-1492

  Yamaguchi, Kiyoshi ^a   Sakai, Michihiro ^b   Kim, Joohun ^a   Tsunesumi, Shin ichiro ^a   Fujii, Tomoaki ^a   Ikenoue, Tsuneo ^a   Yamada, Yoshinao ^c   Akiyama, Yoshiyuki ^c   Muto, Yasuhiko ^c   Yamaguchi, Rui ^b   Miyano, Satoru ^b   Nakamura, Yusuke ^b   Furukawa, Yoichi ^a  

^a Advanced Clinical Research Center   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Tokyo Hitachi Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; BIOLOGICAL MARKER; MINICHROMOSOME MAINTENANCE PROTEIN; MORF4 RELATED GENE BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL DIVISION; CELL PROLIFERATION; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA REPLICATION; GENE AMPLIFICATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MINICHROMOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; AGED, 80 AND OVER; CARRIER PROTEINS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; RNA, SMALL INTERFERING;

EID: 79960417976     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.01971.x     Document Type: Article

References (22)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49.
2. Gellad ZF, Provenzale D. Colorectal cancer: national and international perspective on the burden of disease and public health impact. Gastroenterology 2010; 138: 2177-90.
3. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.
4. Hamamoto R, Furukawa Y, Morita M et al. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat Cell Biol 2004; 6: 731-40.
5. Yagyu R, Furukawa Y, Lin YM, Shimokawa T, Yamamura T, Nakamura Y. A novel oncoprotein RNF43 functions in an autocrine manner in colorectal cancer. Int J Oncol 2004; 25: 1343-8.
6. Yuki D, Lin YM, Fujii Y, Nakamura Y, Furukawa Y. Isolation of LEM domain-containing 1, a novel testis-specific gene expressed in colorectal cancers. Oncol Rep 2004; 12: 275-80.
7. Kobayashi T, Masaki T, Sugiyama M, Atomi Y, Furukawa Y, Nakamura Y. A gene encoding a family with sequence similarity 84, member A (FAM84A) enhanced migration of human colon cancer cells. Int J Oncol 2006; 29: 341-7.
8. Obama K, Kato T, Hasegawa S, Satoh S, Nakamura Y, Furukawa Y. Overexpression of peptidyl-prolyl isomerase-like 1 is associated with the growth of colon cancer cells. Clin Cancer Res 2006; 12: 70-6.
9. Sakai M, Shimokawa T, Kobayashi T et al. Elevated expression of C10orf3 (chromosome 10 open reading frame 3) is involved in the growth of human colon tumor. Oncogene 2006; 25: 480-6.
10. Cai Y, Jin J, Tomomori-Sato C et al. Identification of new subunits of the multiprotein mammalian TRRAP/TIP60-containing histone acetyltransferase complex. J Biol Chem 2003; 278: 42733-6.
11. Yamaguchi K, Sakai M, Shimokawa T, Yamada Y, Nakamura Y, Furukawa Y. C20orf20 (MRG-binding protein) as a potential therapeutic target for colorectal cancer. Br J Cancer 2010; 102: 325-31.
12. Al-Shahrour F, Minguez P, Tarraga J et al. FatiGO +: a functional profiling tool for genomic data. Integration of functional annotation, regulatory motifs and interaction data with microarray experiments. Nucleic Acids Res 2007; 35: W91-6.
13. Johnston PG, O'Brien MJ, Dervan PA, Carney DN. Immunohistochemical analysis of cell kinetic parameters in colonic adenocarcinomas, adenomas, and normal mucosa. Hum Pathol 1989; 20: 696-700.
14. Carvalho B, Postma C, Mongera S et al. Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression. Gut 2009; 58: 79-89.
15. Tatsumi Y, Sugimoto N, Yugawa T, Narisawa-Saito M, Kiyono T, Fujita M. Deregulation of Cdt1 induces chromosomal damage without rereplication and leads to chromosomal instability. J Cell Sci 2006; 119: 3128-40.
16. Vaziri C, Saxena S, Jeon Y et al. A p53-dependent checkpoint pathway prevents rereplication. Mol Cell 2003; 11: 997-1008.
17. Arentson E, Faloon P, Seo J et al. Oncogenic potential of the DNA replication licensing protein CDT1. Oncogene 2002; 21: 1150-8.
18. Davies RJ, Freeman A, Morris LS et al. Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool. Lancet 2002; 359: 1917-19.
19. Ishimi Y, Okayasu I, Kato C et al. Enhanced expression of Mcm proteins in cancer cells derived from uterine cervix. Eur J Biochem 2003; 270: 1089-101.
20. Meng MV, Grossfeld GD, Williams GH et al. Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer. Clin Cancer Res 2001; 7: 2712-18.
21. Ramnath N, Hernandez FJ, Tan DF et al. MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer. J Clin Oncol 2001; 19: 4259-66.
22. Williams GH, Swinn R, Prevost AT et al. Diagnosis of oesophageal cancer by detection of minichromosome maintenance 5 protein in gastric aspirates. Br J Cancer 2004; 91: 714-19.